iShares Neuroscience and Healthcare ETF - Common Stock (IBRN) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
IBRN
Shares outstanding
149,920
Price per share
$32.57
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
94,951
Total reported value
$2,543,564
% of total 13F portfolios
0%
Share change
-29
Value change
-$396
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of iShares Neuroscience and Healthcare ETF - Common Stock (IBRN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock Portfolio Management LLC 63% -8.7% $2,003,140 -$191,790 94,000 -8.7% BlackRock Portfolio Management LLC 31 May 2025

As of 30 Sep 2025, 4 institutional investors reported holding 94,951 shares of iShares Neuroscience and Healthcare ETF - Common Stock (IBRN). This represents 63% of the company’s total 149,920 outstanding shares.

Top 5 Institutional Shareholders

The largest institutional shareholders of iShares Neuroscience and Healthcare ETF - Common Stock (IBRN) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 63% 94,000 0% 0% $2,518,486
PRINCIPAL SECURITIES, INC. 0.49% 732 0% 0% $19,612
CWM, LLC 0.11% 163 0% 0% $4,000
HARBOUR INVESTMENTS, INC. 0.04% 56 0% $1,466
UBS Group AG 0% 0 -100% $0

Institutional Holders of iShares Neuroscience and Healthcare ETF - Common Stock (IBRN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 94,951 $2,543,564 -$396 $26.49 4
2025 Q2 94,980 $2,081,147 -$455,300 $21.91 4
2025 Q1 115,510 $2,584,171 +$264,000 $23.46 4
2024 Q4 103,732 $2,635,094 -$327,149 $25.40 2
2024 Q3 116,944 $2,925,846 +$94,068 $25.02 5
2024 Q2 113,196 $2,669,228 -$330,255 $23.58 4
2024 Q1 125,628 $3,213,003 -$81,215 $25.57 4
2023 Q4 128,842 $3,379,042 -$1,365,101 $26.23 3
2023 Q3 180,891 $3,797,758 +$64,522 $21.00 3
2023 Q2 177,823 $4,321,524 -$106,248 $24.30 3
2023 Q1 182,193 $4,346,135 -$44,635 $23.85 2
2022 Q4 184,063 $4,786,735 -$335,745 $26.01 2
2022 Q3 196,971 $4,886,000 +$4,886,000 $24.80 2